SCHEMBL9920580

SCHEMBL9920580

c1ccc(-c2cc(-c3ccccc3)nc(-c3cccc(-c4cccc(-c5nc(-c6ccccc6)cc(-c6ccccc6)n5)c4)c3)n2)cc1

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 9/20 0.68
KMT2A Q03164 9/20 0.68
MAPT P10636 5/20 0.68
ALDH1A1 P00352 4/20 0.68
HPGD P15428 4/20 0.68
KDM4E B2RXH2 2/20 0.68
LMNA P02545 2/20 0.68
NTSR1 P30989 1/20 0.61
ADORA2A P29274 2/20 0.58
ADORA1 P30542 2/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
GLA P06280 1/20 0.56
RAB9A P51151 1/20 0.54
TDP1 Q9NUW8 2/20 0.52
AGTR1 P30556 1/20 0.52
TSHR P16473 1/20 0.52
ATM Q13315 1/20 0.52
MAPK1 P28482 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17721031 0.98 MEN1 (0.66) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18698109 0.98 MEN1 (0.66) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17720996 0.98 MEN1 (0.66) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17721033 0.96 MEN1 (0.63) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18134313 0.96 MEN1 (0.69) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL24312447 0.96 MEN1 (0.63) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL15458642 0.96 MEN1 (0.63) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18650156 0.96 MEN1 (0.63) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19997865 0.96 MEN1 (0.68) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19997863 0.96 MEN1 (0.68) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651904-B1 BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2014-11-12 EP disclosed
US-8362246-B2 Bispyrimidines for electronic applications BASF SE (DE) 2013-01-29 US disclosed
US-8362246-B2 Bispyrimidines for electronic applications BASF SE (DE) 2013-01-29 US disclosed
WO-2012080052-A1 BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2012-06-21 WO disclosed
US-20120149904-A1 BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2012-06-14 US disclosed
US-20120149904-A1 BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149904-A1 BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS DPYD, TYMP, TYMS MEN1 3376/4885KMT2A 2215/4885MAPT 1242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.